Valuation is reasonable: with FY26 consensus EPS of $26.25 and a 13x multiple, CB is about 8% undervalued, targeting $341 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results